Info

India began administration of COVID-19 vaccines on 16 January 2021 (154 days ago). As of 19 June 2021, India has administered 272,388,783 doses overall, including first and second doses of the currently-approved vaccines. Two vaccines received approval for emergency use in India at the onset of the programme; Covishield—a brand of the Oxford–AstraZeneca vaccine manufactured by the Serum Institute of India, and Covaxin, which was developed by Bharat Biotech. In April 2021, the Indian government approved the Russian Sputnik V vaccine (which is distributed locally by Dr. Reddy's Laboratories) as a third vaccine, which began use in May 2021.

Vaccination in Uttar Pradesh

(Till June 2021)